Guideline Development Group


Statement 7: VERIFY THE PATIENT IS TAKING AN ANTICOAGULANT



Yüklə 0,54 Mb.
səhifə21/46
tarix25.12.2016
ölçüsü0,54 Mb.
#2801
1   ...   17   18   19   20   21   22   23   24   ...   46

Statement 7: VERIFY THE PATIENT IS TAKING AN ANTICOAGULANT.


When a patient has a recently diagnosed LE DVT, the physical therapist should verify if the patient is taking an anticoagulant medication, what type of anticoagulant medication, and when the anticoagulant medication was initiated. (Evidence Quality: V; Recommendation Strength: Theoretical/foundational)

Action Statement Profile

Aggregate Evidence Quality: Level V

Benefit: Decreased risk of a PE in patients who are adequately anti-coagulated

Risk, Harm, Cost: Risk of bleeding with anticoagulation, risk of adverse effects with restrictions in inactivity, and cost of new anticoagulants may be prohibitive in those with inadequate pharmacy insurance coverage.

Benefit-Harm Assessment: Preponderance of benefit over harm

Value Judgments: Intentional Vagueness: This clinical practice guideline has provided therapeutic ranges for anticoagulants that have been provided by the manufacturers due to the limited evidence beyond this. While the recommendation strength is weak based upon scientific evidence, the GDG considers it prudent to follow the manufacturer’s recommendations.

Role of Patient Preference: Patients should be informed of the importance for continuing anticoagulation upon discharge from the hospital as different anticoagulants require monitoring, cost, and modification of diet and bleeding risk.

Exclusions: None



Yüklə 0,54 Mb.

Dostları ilə paylaş:
1   ...   17   18   19   20   21   22   23   24   ...   46




Verilənlər bazası müəlliflik hüququ ilə müdafiə olunur ©azkurs.org 2024
rəhbərliyinə müraciət

gir | qeydiyyatdan keç
    Ana səhifə


yükləyin